Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription 14.05.2018 1 Antimicrob Agents Chemother 1 Eur J Clin Microbiol Infect Dis 4 Eur Respir J 1 J Clin Microbiol 3 J Infect 1 Lancet 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
   Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
   Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

2. ORIKIRIZA P, Nansumba M, Nyehangane D, Bastard M, et al
   Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
   Eur J Clin Microbiol Infect Dis. 2018 May 8. pii: 10.1007/s10096-018-3272.
   PubMed     Text format     Abstract available
   
   

   
   Eur Respir J

3. ASSEFA Y, Assefa Y, Woldeyohannes S, Hamada Y, et al
   Three-month daily Rifampicin and Isoniazid compared to six or nine-month Isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
   Eur Respir J. 2018 May 10. pii: 13993003.00395-2018.
   PubMed     Text format    
   
   
4. ABUBAKAR I, Matteelli A, de Vries G, Zenner D, et al
   Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.
   Eur Respir J. 2018;51.
   PubMed     Text format    
   
   
5. MOHR E, Hughes J, Reuter A, Trivino Duran L, et al
   Delamanid for Rifampicin-Resistant Tuberculosis: A Retrospective Study from South Africa.
   Eur Respir J. 2018 May 3. pii: 13993003.00017-2018.
   PubMed     Text format     Abstract available
   
   
6. MUSTAZZOLU A, Borroni E, Maria Cirillo D, Giannoni F, et al
   Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009-2016.
   Eur Respir J. 2018 May 3. pii: 13993003.00070-2018.
   PubMed     Text format    
   
   

   
   J Clin Microbiol

7. THEEL ES, Hilgart H, Breen-Lyles M, McCoy K, et al
   Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon-gamma Release Assays in Patients at Risk for Tuberculosis and in Healthcare Workers.
   J Clin Microbiol. 2018 May 9. pii: JCM.00614-18. doi: 10.1128/JCM.00614.
   PubMed     Text format     Abstract available
   
   

   
   J Infect

8. E BS, Magda E, YuRong Y, Guangyu G, et al
   Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy.
   J Infect. 2018 May 7. pii: S0163-4453(18)30122.
   PubMed     Text format     Abstract available
   
   
9. ZHANG H, Xin H, Li X, Li H, et al
   Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: a Systematic Review and Meta-Analysis.
   J Infect. 2018 May 7. pii: S0163-4453(18)30112.
   PubMed     Text format     Abstract available
   
   
10. KIM JY, Park JH, Kim MC, Cha HH, et al
    Combined IFN-gamma and TNF-alpha release assay for differentiating active tuberculosis from latent tuberculosis infection.
    J Infect. 2018 May 7. pii: S0163-4453(18)30116.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

11. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    
    
    

    
    PLoS One

12. MANANA PN, Kuonza L, Musekiwa A, Koornhof H, et al
    Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa.
    PLoS One. 2018;13:e0197022.
    PubMed     Text format     Abstract available
    
    
13. PIENAAR E, Linderman JJ, Kirschner DE
    Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
    PLoS One. 2018;13:e0196322.
    PubMed     Text format     Abstract available
    
    
14. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Text format     Abstract available
    
    
15. JORSTAD MD, Marijani M, Dyrhol-Riise AM, Sviland L, et al
    MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar.
    PLoS One. 2018;13:e0196723.
    PubMed     Text format     Abstract available
    
    
16. PADMASAWITRI TIA, Frederix GW, Alisjahbana B, Klungel O, et al
    Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
    PLoS One. 2018;13:e0193293.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: